Related references
Note: Only part of the references are listed.Association of volumetric bone mineral density with abdominal aortic calcification in African ancestry men
A. L. Kuipers et al.
OSTEOPOROSIS INTERNATIONAL (2014)
The relationship between inhibitors of the Wnt signalling pathway (Dickkopf-1(DKK1) and sclerostin), bone mineral density, vascular calcification and arterial stiffness in post-menopausal women
Geeta Hampson et al.
BONE (2013)
Resorption Controls Bone Anabolism Driven by Parathyroid Hormone (PTH) Receptor Signaling in Osteocytes
Yumie Rhee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
Increased Cortical Porosity in Type 2 Diabetic Postmenopausal Women With Fragility Fractures
Janina M. Patsch et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2013)
Bariatric Surgery Results in Cortical Bone Loss
Emily M. Stein et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2013)
Vitamin D and the cardiovascular system
L. A. Beveridge et al.
OSTEOPOROSIS INTERNATIONAL (2013)
Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional links
A. Fisher et al.
CLINICAL INTERVENTIONS IN AGING (2013)
Reduction of volumetric bone mineral density in postmenopausal women with hepatitis C virus-correlated chronic liver disease: A peripheral quantitative computed tomography (pQCT) study
Agostino Gaudio et al.
EUROPEAN JOURNAL OF INTERNAL MEDICINE (2012)
Osteocyte RANKL: New insights into the control of bone remodeling
Jinhu Xiong et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2012)
Vascular Calcification Is Associated with Cortical Bone Loss in Chronic Renal Failure Rats with and without Ovariectomy: The Calcification Paradox
Tineke M. De Schutter et al.
AMERICAN JOURNAL OF NEPHROLOGY (2011)
Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway
Asiri R. Wijenayaka et al.
PLOS ONE (2011)
Glucocorticoids, osteocytes, and skeletal fragility: The role of bone vascularity
Robert S. Weinstein
BONE (2010)
Augmentation of cortical bone mineral density in women with polycystic ovary syndrome: a peripheral quantitative computed tomography (pQCT) study
D. Kassanos et al.
HUMAN REPRODUCTION (2010)
Assessment of the skeletal status by peripheral quantitative computed tomography of the forearm: Short-term precision in vivo and comparison to dual X-ray absorptiometry
Stephan Grampp et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The association between carotid or femoral atherosclerosis and low bone mass in postmenopausal women referred for osteoporosis screening Does osteoprotegerin play a role?
P. Pennisi et al.
MATURITAS (2010)
Association of serum osteoprotegerin with ankle-brachial index and urine albumin: Creatinine ratio in African-Americans and non-Hispanic whites
Zeenat Ali et al.
ATHEROSCLEROSIS (2009)
Peripheral Arterial Disease Is Associated With Higher Rates of Hip Bone Loss and Increased Fracture Risk in Older Men
Tracie C. Collins et al.
CIRCULATION (2009)
Divergent Effects of Glucocorticoids on Cortical and Trabecular Compartment BMD in Childhood Nephrotic Syndrome
Rachel J. Wetzsteon et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2009)
Peripheral arterial disease and osteoporosis in older adults: the Rancho Bernardo Study
D. von Muehlen et al.
OSTEOPOROSIS INTERNATIONAL (2009)
Soluble receptor activator of nuclear factor-κB ligand and risk for cardiovascular disease
Stefan Kiechl et al.
CIRCULATION (2007)
Vascular calcification and osteoporosis-from clinical observation towards molecular understanding
L. C. Hofbauer et al.
OSTEOPOROSIS INTERNATIONAL (2007)
Volumetric and areal bone mineral density measures are associated with cardiovascular disease in older men and women: The health, aging, and body composition study
G. N. Farhat et al.
CALCIFIED TISSUE INTERNATIONAL (2006)
Cortical PQCT measures are associated with fractures in dialysis patients
SA Jamal et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2006)
Increased prevalence of peripheral arterial disease in osteoporotic postmenopausal women
RA Mangiafico et al.
JOURNAL OF BONE AND MINERAL METABOLISM (2006)
Bone mineral density and the risk of peripheral arterial disease in men and women: results from Mr. and Ms Os, Hong Kong
SYS Wong et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Relationship between osteoporosis and cardiovascular disease in postmenopausal women
LB Tankó et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2005)
Serum levels of osteoprotegerin and RANKL in patients with ST elevation acute myocardial infarction
A Crisafulli et al.
CLINICAL SCIENCE (2005)
Hypovitaminosis D, impaired bone turnover and low bone mass are common in patients with peripheral arterial disease
A Fahrleitner-Pammer et al.
OSTEOPOROSIS INTERNATIONAL (2005)
Estimation of bone mineral density and architectural parameters of the distal radius in hemodialysis patients using peripheral quantitative computed tomography
K Hasegawa et al.
JOURNAL OF BIOMECHANICS (2004)
Low bone mineral density in the hip as a marker of advanced atherosclerosis in elderly women
LB Tankó et al.
CALCIFIED TISSUE INTERNATIONAL (2003)
Low serum levels of soluble RANK ligand are associated with the presence of coronary artery disease in men
M Schoppet et al.
CIRCULATION (2003)
Bone mineral density and the risk of peripheral arterial disease: The Rotterdam Study
M van der Klift et al.
CALCIFIED TISSUE INTERNATIONAL (2002)
RANK ligand and osteoprotegerin - Paracrine regulators of bone metabolism and vascular function
M Schoppet et al.
ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2002)
Drug therapy - Medical treatment of peripheral arterial disease and claudication.
WR Hiatt
NEW ENGLAND JOURNAL OF MEDICINE (2001)
Share Paper
